# OnCo record nct02022358 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02022358/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02022358", "NCT02022358" ;
  schema:name "Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?"@en ;
  schema:description "A phase 2 trial of Glucarpidase, Methotrexate and Leucovorin in Osteosarcoma, run by University College, London, recorded as terminated on the registry."@en ;
  schema:url <https://onco.cc/trials/nct02022358/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02022358> ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/osteosarcoma/> ;
  onco:drugs <https://onco.cc/drugs/glucarpidase/>, <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/drugs/leucovorin/> .